H
HLB Therapeutics Co Ltd
KOSDAQ:115450
HLB Therapeutics Co Ltd
KOSDAQ:115450
Price:
2 950
KRW
-0.67%
Market Closed
Market Cap:
₩261.3B
Balance Sheet
Balance Sheet Decomposition
HLB Therapeutics Co Ltd
HLB Therapeutics Co Ltd
Balance Sheet Decomposition is not available for
HLB Therapeutics Co Ltd
HLB Therapeutics Co Ltd
Balance Sheet
HLB Therapeutics Co Ltd
HLB Therapeutics Co Ltd
Currency: KRW
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
10
|
170
|
855
|
2 356
|
631
|
1 578
|
9 226
|
7 986
|
3 855
|
1 895
|
5 776
|
4 283
|
5 407
|
16 654
|
43 198
|
13 930
|
99 873
|
45 821
|
23 709
|
17 934
|
|
| Cash Equivalents |
10
|
170
|
855
|
2 356
|
631
|
1 578
|
9 226
|
7 986
|
3 855
|
1 895
|
5 776
|
4 283
|
5 407
|
16 654
|
43 198
|
13 930
|
99 873
|
45 821
|
23 709
|
17 934
|
|
| Short-Term Investments |
3 133
|
4 191
|
3 010
|
4 545
|
7 700
|
11 876
|
4 130
|
0
|
0
|
0
|
4 000
|
300
|
500
|
200
|
4 949
|
14 855
|
634
|
18 131
|
8 644
|
19 839
|
|
| Total Receivables |
477
|
1 506
|
1 882
|
2 909
|
1 448
|
2 391
|
9 813
|
8 701
|
3 115
|
2 431
|
2 932
|
2 757
|
4 709
|
17 219
|
9 935
|
5 651
|
8 949
|
8 729
|
10 006
|
9 118
|
|
| Accounts Receivables |
477
|
1 506
|
1 881
|
2 871
|
1 422
|
2 317
|
8 514
|
7 403
|
2 635
|
2 375
|
2 286
|
2 105
|
2 269
|
13 112
|
8 534
|
4 537
|
6 633
|
8 009
|
9 539
|
8 671
|
|
| Other Receivables |
0
|
0
|
1
|
38
|
26
|
74
|
1 299
|
1 298
|
480
|
56
|
646
|
652
|
2 440
|
4 107
|
1 401
|
1 114
|
2 316
|
720
|
467
|
447
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
2 566
|
2 058
|
1 679
|
1 448
|
1 594
|
1 748
|
1 833
|
4 342
|
3 310
|
3 236
|
2 345
|
6 455
|
5 336
|
5 373
|
|
| Other Current Assets |
165
|
109
|
182
|
101
|
344
|
83
|
3 692
|
6 624
|
1 409
|
38 234
|
2 110
|
243
|
111
|
429
|
635
|
186
|
1 451
|
875
|
2 130
|
1 860
|
|
| Total Current Assets |
3 785
|
5 976
|
5 928
|
9 911
|
10 123
|
15 929
|
29 427
|
25 369
|
10 058
|
44 009
|
16 413
|
9 331
|
12 561
|
38 844
|
62 028
|
37 859
|
113 253
|
80 012
|
49 825
|
54 125
|
|
| PP&E Net |
67
|
2 516
|
2 456
|
3 990
|
8 546
|
6 977
|
13 384
|
11 285
|
10 187
|
9 984
|
9 716
|
9 502
|
9 275
|
9 096
|
9 513
|
9 162
|
9 781
|
15 780
|
10 068
|
9 530
|
|
| PP&E Gross |
67
|
2 516
|
2 456
|
3 990
|
8 546
|
6 977
|
13 384
|
11 285
|
10 187
|
9 984
|
9 716
|
9 502
|
9 275
|
9 096
|
9 513
|
9 162
|
9 781
|
15 780
|
10 068
|
9 530
|
|
| Accumulated Depreciation |
70
|
152
|
266
|
383
|
666
|
816
|
1 766
|
3 008
|
2 265
|
2 834
|
3 134
|
2 646
|
2 963
|
3 397
|
3 380
|
3 705
|
4 145
|
11 035
|
4 057
|
4 391
|
|
| Intangible Assets |
1
|
117
|
117
|
118
|
120
|
1 582
|
1 648
|
1 028
|
278
|
408
|
12 438
|
24 781
|
36 879
|
40 006
|
50 027
|
54 337
|
61 511
|
67 732
|
73 996
|
83 682
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
13 278
|
11 882
|
9 467
|
190
|
190
|
190
|
190
|
7 494
|
6 392
|
4 826
|
382
|
1 075
|
5 388
|
5 388
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
200
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
10
|
100
|
70
|
40
|
10
|
6 501
|
10
|
401
|
316
|
3 368
|
11 002
|
7 509
|
3 567
|
11 800
|
11 032
|
15 322
|
3 715
|
20 335
|
58 608
|
61 804
|
|
| Other Long-Term Assets |
307
|
406
|
3 114
|
1 949
|
2 276
|
1 204
|
4 486
|
4 153
|
6 381
|
560
|
588
|
335
|
239
|
417
|
527
|
432
|
1 070
|
2 709
|
2 910
|
5 264
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
13 278
|
11 882
|
9 467
|
190
|
190
|
190
|
190
|
7 494
|
6 392
|
4 826
|
382
|
1 075
|
5 388
|
5 388
|
|
| Total Assets |
4 170
N/A
|
9 116
+119%
|
11 686
+28%
|
16 008
+37%
|
21 075
+32%
|
32 193
+53%
|
62 233
+93%
|
54 317
-13%
|
36 686
-32%
|
58 518
+60%
|
50 347
-14%
|
51 648
+3%
|
62 711
+21%
|
107 657
+72%
|
139 519
+30%
|
121 938
-13%
|
189 711
+56%
|
187 643
-1%
|
200 795
+7%
|
219 793
+9%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1 366
|
1 392
|
733
|
647
|
803
|
945
|
1 028
|
12 543
|
9 336
|
2 877
|
1 272
|
2 517
|
8 183
|
4 817
|
|
| Accrued Liabilities |
125
|
474
|
486
|
527
|
1 166
|
681
|
1 881
|
1 133
|
720
|
612
|
854
|
893
|
766
|
938
|
694
|
815
|
1 819
|
1 510
|
902
|
1 106
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
21 969
|
21 360
|
19 900
|
4 600
|
1 700
|
1 500
|
0
|
0
|
0
|
0
|
0
|
2 708
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
206
|
0
|
0
|
0
|
1 275
|
667
|
667
|
2 500
|
0
|
0
|
0
|
8 802
|
14 123
|
8 853
|
48 578
|
13 116
|
50 806
|
49 238
|
8 060
|
17 982
|
|
| Other Current Liabilities |
746
|
567
|
235
|
286
|
605
|
648
|
15 298
|
6 147
|
2 386
|
24 949
|
1 189
|
933
|
888
|
1 352
|
1 500
|
1 527
|
2 820
|
2 655
|
9 645
|
8 000
|
|
| Total Current Liabilities |
1 078
|
1 041
|
721
|
813
|
3 046
|
1 996
|
41 181
|
32 532
|
23 739
|
30 808
|
4 546
|
13 073
|
16 805
|
23 686
|
60 108
|
18 335
|
56 717
|
58 628
|
26 791
|
31 904
|
|
| Long-Term Debt |
106
|
0
|
0
|
2 000
|
2 125
|
1 167
|
932
|
2 932
|
1 372
|
3 907
|
10 690
|
0
|
0
|
0
|
190
|
219
|
321
|
185
|
1 962
|
5 371
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
21
|
21
|
21
|
21
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
407
|
305
|
245
|
243
|
3 404
|
3 083
|
5 569
|
12 768
|
12 160
|
10 952
|
11 360
|
11 408
|
11 053
|
24 404
|
|
| Other Liabilities |
234
|
362
|
454
|
732
|
1 119
|
1 533
|
1 740
|
4 766
|
1 197
|
1 262
|
1 605
|
1 592
|
1 873
|
2 519
|
3 125
|
3 078
|
2 634
|
715
|
523
|
649
|
|
| Total Liabilities |
1 418
N/A
|
1 403
-1%
|
1 174
-16%
|
3 545
+202%
|
6 289
+77%
|
4 695
-25%
|
43 447
+825%
|
40 535
-7%
|
26 552
-34%
|
36 244
+37%
|
20 265
-44%
|
17 769
-12%
|
24 268
+37%
|
38 994
+61%
|
75 583
+94%
|
32 585
-57%
|
71 032
+118%
|
70 936
0%
|
40 329
-43%
|
62 329
+55%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
1 149
|
1 149
|
1 149
|
1 149
|
1 747
|
2 224
|
4 961
|
4 961
|
4 961
|
9 461
|
10 143
|
11 057
|
11 568
|
12 246
|
12 506
|
13 475
|
15 668
|
15 992
|
37 016
|
40 070
|
|
| Retained Earnings |
290
|
4 656
|
7 441
|
9 379
|
11 681
|
15 616
|
17 548
|
23 942
|
27 761
|
29 459
|
33 949
|
39 270
|
44 177
|
39 773
|
56 542
|
73 451
|
90 644
|
1 916
|
4 862
|
30 176
|
|
| Additional Paid In Capital |
1 893
|
1 907
|
1 921
|
1 934
|
1 358
|
12 217
|
38 715
|
38 715
|
38 715
|
48 059
|
51 727
|
61 688
|
68 559
|
93 371
|
103 821
|
143 198
|
187 735
|
94 175
|
122 061
|
133 173
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
0
|
7 640
|
5 050
|
1 108
|
859
|
1 407
|
6 606
|
1 255
|
995
|
1 742
|
272
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
2 545
|
7 352
|
4 138
|
3 856
|
3 856
|
3 856
|
3 856
|
414
|
414
|
414
|
414
|
414
|
414
|
484
|
1 120
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
11
|
1 814
|
1 925
|
1 931
|
1 623
|
790
|
1 798
|
2 373
|
3 158
|
62
|
5 078
|
7 874
|
8 477
|
15 790
|
|
| Total Equity |
2 752
N/A
|
7 713
+180%
|
10 512
+36%
|
12 463
+19%
|
14 785
+19%
|
27 498
+86%
|
18 786
-32%
|
13 782
-27%
|
10 134
-26%
|
22 274
+120%
|
30 083
+35%
|
33 879
+13%
|
38 443
+13%
|
68 664
+79%
|
63 936
-7%
|
89 354
+40%
|
118 679
+33%
|
116 708
-2%
|
160 466
+37%
|
157 465
-2%
|
|
| Total Liabilities & Equity |
4 170
N/A
|
9 116
+119%
|
11 686
+28%
|
16 008
+37%
|
21 075
+32%
|
32 193
+53%
|
62 233
+93%
|
54 317
-13%
|
36 686
-32%
|
58 518
+60%
|
50 347
-14%
|
51 648
+3%
|
62 711
+21%
|
107 657
+72%
|
139 519
+30%
|
121 938
-13%
|
189 711
+56%
|
187 643
-1%
|
200 795
+7%
|
219 793
+9%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
6
|
9
|
13
|
26
|
28
|
28
|
43
|
46
|
50
|
54
|
57
|
58
|
63
|
73
|
72
|
81
|
88
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
